InvestorsHub Logo
Followers 22
Posts 2520
Boards Moderated 0
Alias Born 01/07/2015

Re: None

Saturday, 07/06/2019 4:35:55 PM

Saturday, July 06, 2019 4:35:55 PM

Post# of 83
MYND VOTE TO APPROVE EMMAUS MERGER TUESDAY 7/9!

Emmaus Life Sciences has a FDA approved drug for Sickle Cell disease, Endari. This will be followed by MYND spinning off their telepsychiatry/AI PEER 4.0 device into a newly formed NASDAQ listed company, TeleMYnd...

In doing some research it seems the market opportunity for Sickle Cell is quite large and expected to more than double in the next four years.

Sickle Cell market size $2.1B growing to $4.5B by 2025. Also Emmaus is listed as the #1 key player!


here is the study...
https://www.marketwatch.com/press-release/sickle-cell-anemia-therapeutics-market-size-to-surge-at-110-cagr-and-hit-usd-4500-million-by-2025-2019-04-09

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MYND News